Will Johnson & Johnson’s Split Pay Off? History Says No.

3 years ago 397

This transcript is for your personal, non-commercial usage only. To bid presentation-ready copies for organisation to your colleagues, clients oregon customers sojourn http://www.djreprints.com.

https://www.barrons.com/articles/johnson-and-johnson-split-stock-51636764827


Updated Nov. 12, 2021 8:40 p.m. ET / Original Nov. 12, 2021 8:15 p.m. ET

  • Order Reprints
  • Print Article

Investors’ excitement implicit a breakup of Johnson & Johnson was somewhat muted connected Friday, arsenic eagerness to divided a conglomerate ran into the disappointing caller grounds of Big Pharma spinoffs.

Johnson & Johnson (ticker: JNJ) said it would abstracted its user wellness part into a caller company, leaving down a pharmaceutical and medical-device concern that it said would inactive beryllium the largest healthcare institution successful the world.

The...


Read Entire Article